Chemomab Therapeutics (CMMB)
(Delayed Data from NSDQ)
$0.87 USD
0.00 (-0.23%)
Updated May 16, 2024 04:00 PM ET
After-Market: $0.84 -0.03 (-3.45%) 7:54 PM ET
2-Buy of 5 2
D Value D Growth C Momentum D VGM
Brokerage Reports
0 items in cart
Chemomab Therapeutics Ltd. Sponsored ADR [CMMB]
Reports for Purchase
Showing records 1 - 8 ( 8 total )
Company: Chemomab Therapeutics Ltd. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Chemomab Therapeutics Ltd. Sponsored ADR
Industry: Medical - Biomedical and Genetics
PSC Ph 2 Enrollment Completes Early Accelerating Top-line Results to Mid-Year
Provider: Roth Capital Partners, Inc.
Analyst: WHITE J
Company: Chemomab Therapeutics Ltd. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Chemomab Therapeutics Ltd. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Resuming Coverage with a Buy and $7 PT
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Chemomab Therapeutics Ltd. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Biotechnology -Healthcare Coverage Update
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Chemomab Therapeutics Ltd. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Chemomab Therapeutics Ltd. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Chemomab Therapeutics Ltd. Sponsored ADR
Industry: Medical - Biomedical and Genetics
|